32 related articles for article (PubMed ID: 15157732)
1. Decision-theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta-binomial distribution.
Hee SW; Parsons N; Stallard N
Biom J; 2018 Mar; 60(2):232-245. PubMed ID: 28744892
[TBL] [Abstract][Full Text] [Related]
2. The Sequential Probability Ratio Test: An efficient alternative to exact binomial testing for Clean Water Act 303(d) evaluation.
Chen C; Gribble MO; Bartroff J; Bay SM; Goldstein L
J Environ Manage; 2017 May; 192():89-93. PubMed ID: 28142127
[TBL] [Abstract][Full Text] [Related]
3. Practical and robust test for comparing binomial proportions in the randomized phase II setting.
Attwood K; Park S; Hutson AD
Pharm Stat; 2022 Mar; 21(2):361-371. PubMed ID: 34626075
[TBL] [Abstract][Full Text] [Related]
4. A Phase II Study of Pelareorep (REOLYSIN
Mahalingam D; Goel S; Aparo S; Patel Arora S; Noronha N; Tran H; Chakrabarty R; Selvaggi G; Gutierrez A; Coffey M; Nawrocki ST; Nuovo G; Mita MM
Cancers (Basel); 2018 May; 10(6):. PubMed ID: 29799479
[TBL] [Abstract][Full Text] [Related]
5. A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.
Ramnath N; Daignault-Newton S; Dy GK; Muindi JR; Adjei A; Elingrod VL; Kalemkerian GP; Cease KB; Stella PJ; Brenner DE; Troeschel S; Johnson CS; Trump DL
Cancer Chemother Pharmacol; 2013 May; 71(5):1173-82. PubMed ID: 23435876
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase II designs in cancer clinical trials: current status and future directions.
Lee JJ; Feng L
J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154
[TBL] [Abstract][Full Text] [Related]
7. Sample size tables for exact single-stage phase II designs.
A'Hern RP
Stat Med; 2001 Mar; 20(6):859-66. PubMed ID: 11252008
[TBL] [Abstract][Full Text] [Related]
8. On group sequential designs comparing two binomial proportions.
Kepner JL
J Biopharm Stat; 2010 Jan; 20(1):145-59. PubMed ID: 20077254
[TBL] [Abstract][Full Text] [Related]
9. Optimal and minimax three-stage designs for phase II oncology clinical trials.
Chen K; Shan M
Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
[TBL] [Abstract][Full Text] [Related]
10. Sample size re-estimation in group-sequential response-adaptive clinical trials.
Morgan CC
Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
[TBL] [Abstract][Full Text] [Related]
11. On Simon's two-stage design for single-arm phase IIA cancer clinical trials under beta-binomial distribution.
Liu J; Lin Y; Shih WJ
Stat Med; 2010 May; 29(10):1084-95. PubMed ID: 20077506
[TBL] [Abstract][Full Text] [Related]
12. Samples of exact k-stage group sequential designs for Phase II and Pilot studies.
Kepner JL; Chang MN
Control Clin Trials; 2004 Jun; 25(3):326-33. PubMed ID: 15157732
[TBL] [Abstract][Full Text] [Related]
13. Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases.
van der Lee JH; Wesseling J; Tanck MW; Offringa M
J Clin Epidemiol; 2008 Apr; 61(4):324-30. PubMed ID: 18313556
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
